DD234421A5 - Verfahren zur herstellung von substituierten isochromanen und oxepinen - Google Patents

Verfahren zur herstellung von substituierten isochromanen und oxepinen Download PDF

Info

Publication number
DD234421A5
DD234421A5 DD85274121A DD27412185A DD234421A5 DD 234421 A5 DD234421 A5 DD 234421A5 DD 85274121 A DD85274121 A DD 85274121A DD 27412185 A DD27412185 A DD 27412185A DD 234421 A5 DD234421 A5 DD 234421A5
Authority
DD
German Democratic Republic
Prior art keywords
group
hydrogen atom
atoms
alkyl group
atom
Prior art date
Application number
DD85274121A
Other languages
German (de)
English (en)
Inventor
Wolfgang Abele
Herbert Koeppe
Franz Esser
Wolfram Gaida
Wolfgang Hefke
Ilse Streller
Richard Reichl
Werner Traunecker
Original Assignee
��������@���������������@����������������������@���k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ��������@���������������@����������������������@���k�� filed Critical ��������@���������������@����������������������@���k��
Publication of DD234421A5 publication Critical patent/DD234421A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/76Benzo[c]pyrans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D313/00Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02Seven-membered rings
    • C07D313/06Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/08Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
DD85274121A 1984-03-16 1985-03-14 Verfahren zur herstellung von substituierten isochromanen und oxepinen DD234421A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843409612 DE3409612A1 (de) 1984-03-16 1984-03-16 Neue substituierte isochromane und oxepine, deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
DD234421A5 true DD234421A5 (de) 1986-04-02

Family

ID=6230653

Family Applications (1)

Application Number Title Priority Date Filing Date
DD85274121A DD234421A5 (de) 1984-03-16 1985-03-14 Verfahren zur herstellung von substituierten isochromanen und oxepinen

Country Status (18)

Country Link
EP (1) EP0157206A3 (enrdf_load_html_response)
JP (1) JPS60209581A (enrdf_load_html_response)
KR (1) KR850006397A (enrdf_load_html_response)
AU (1) AU4001785A (enrdf_load_html_response)
CS (1) CS247196B2 (enrdf_load_html_response)
DD (1) DD234421A5 (enrdf_load_html_response)
DE (1) DE3409612A1 (enrdf_load_html_response)
DK (1) DK120185A (enrdf_load_html_response)
ES (1) ES8606324A1 (enrdf_load_html_response)
FI (1) FI851022A7 (enrdf_load_html_response)
GR (1) GR850658B (enrdf_load_html_response)
HU (1) HUT37419A (enrdf_load_html_response)
IL (1) IL74616A0 (enrdf_load_html_response)
NO (1) NO851029L (enrdf_load_html_response)
PH (1) PH20880A (enrdf_load_html_response)
PL (1) PL252375A1 (enrdf_load_html_response)
PT (1) PT80115B (enrdf_load_html_response)
ZA (1) ZA851948B (enrdf_load_html_response)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3642331A1 (de) * 1986-12-11 1988-06-23 Basf Ag Basisch substituierte phenylacetonitrile, ihre herstellung und diese enthaltende arzneimittel
CA2019621A1 (en) * 1989-06-23 1990-12-23 Kuniko Hashigaki Arylalkylamine derivatives
EP0450689A1 (en) * 1990-04-02 1991-10-09 Akzo Nobel N.V. New isochromane derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1552004A (en) * 1976-05-26 1979-09-05 Takeda Chemical Industries Ltd Isochroman derivatives

Also Published As

Publication number Publication date
PT80115B (de) 1987-03-24
ES541295A0 (es) 1986-04-01
DK120185D0 (da) 1985-03-15
EP0157206A2 (de) 1985-10-09
NO851029L (no) 1985-09-17
DK120185A (da) 1985-09-17
CS247196B2 (en) 1986-12-18
IL74616A0 (en) 1985-06-30
DE3409612A1 (de) 1985-09-19
JPS60209581A (ja) 1985-10-22
ZA851948B (en) 1986-11-26
EP0157206A3 (de) 1986-06-11
FI851022L (fi) 1985-09-17
PT80115A (de) 1985-04-01
PH20880A (en) 1987-05-27
HUT37419A (en) 1985-12-28
AU4001785A (en) 1985-09-19
ES8606324A1 (es) 1986-04-01
GR850658B (enrdf_load_html_response) 1985-07-11
FI851022A0 (fi) 1985-03-14
PL252375A1 (en) 1985-10-22
KR850006397A (ko) 1985-10-05
FI851022A7 (fi) 1985-09-17

Similar Documents

Publication Publication Date Title
EP0026317B1 (de) Optisch aktive 1,4-Dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE19916108C1 (de) Mit Zuckerresten substituierte 1,4-Benzothiazepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
DE69014351T2 (de) Pyridincarbonsäureamid-Derivate und diese enthaltende pharmazeutische Zusammensetzungen.
EP0229623A2 (de) Diarylalkyl-substituierte Alkylamine, Verfahren zu ihrer Herstellung, ihre Verwendung sowie sie enthaltende Arzneimittel
CH662562A5 (de) 1,2,4-triazol-3-on-verbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische mittel.
DD273833A5 (de) N 9 - cyclopentylsubstituierte adeninderivate
EP0124476B1 (de) Carboxamide, Verfahren zur Herstellung und pharmazeutische Präparate, die diese enthalten
EP0114270B1 (de) Acylderivate von 1,4:3,6-Dianhydro-hexiten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE2149249B2 (de) 4-Amino-6-arylpyrimidine
EP0082364B1 (de) (+)-2-(1-(2,6-Dichlorphenoxy)-ethy1)-1,3-diazacyclopent-2-en, dessen Herstellung und seine Verwendung in pharmazeutischen Präparaten
EP0415065B1 (de) Chromanderivate
EP0025192A2 (de) Substituierte Oxirancarbonsäuren, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende Arzneimittel
EP0410208B1 (de) Chromanderivate
EP0335315B1 (de) Neue Alkanophenone
EP0044989A1 (de) Neue, in 5-Stellung substituierte 5,10-Dihydro-11H-dibenzo (b,e)(1,4)diazepin-11-one, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
EP0213293B1 (de) In 11-Stellung substituierte 5,11-Dihydro-6H-pyrido-[2,3-b][1,4]benzodiazepin-6-one, Verfahren zur ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DD234421A5 (de) Verfahren zur herstellung von substituierten isochromanen und oxepinen
EP0081748A2 (de) Verfahren zur Herstellung von (-)-2-(1-(2,6-Dichlorphenoxy)-ethyl)-1,3-diazacyclopent-2-en
DE3782396T2 (de) Pharmazeutische zusammensetzungen, enthaltend ein 2,4-diphenyl-1,3-dioxane derivat und einen inhibitor des thromboxan a2 synthese.
EP0085893B1 (de) Pyridobenzodiazepinone, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DD154487A5 (de) Verfahren zur herstellung von 1-benzoxepin-5(2h)-on-derivaten
EP0124630A1 (de) Pyrimidin-Thioalkylpyridin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindung enthaltende Arzneimittel
DE69114644T2 (de) 4(5)-Imidazole fähig zur Inhibierung von Aromatase.
EP0167945B1 (de) Phenylethylaminopropiophenon-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
EP0086980B1 (de) Substituierte Dibenzodiazepinone, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel